The existence of Th22, pure Th17 and Th1 cells in CIN and Cervical Cancer along with their frequency variation in different stages of cervical cancer

[1]  You Zhou,et al.  Th22 cells are associated with hepatocellular carcinoma development and progression. , 2014, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[2]  Yanfang Jiang,et al.  A High Frequency of Circulating Th22 and Th17 Cells in Patients with New Onset Graves’ Disease , 2013, PloS one.

[3]  Benjamin Haibe-Kains,et al.  CD4⁺ follicular helper T cell infiltration predicts breast cancer survival. , 2013, The Journal of clinical investigation.

[4]  Xuehao Wang,et al.  IL-22 is related to development of human colon cancer by activation of STAT3 , 2013, BMC Cancer.

[5]  B. Kong,et al.  Distribution of Th17 cells and Foxp3-expressing T cells in tumor-infiltrating lymphocytes in patients with uterine cervical cancer. , 2012, Clinica chimica acta; international journal of clinical chemistry.

[6]  Y. Zhuang,et al.  Increased Circulating Th22 and Th17 Cells are Associated with Tumor Progression and Patient Survival in Human Gastric Cancer , 2012, Journal of Clinical Immunology.

[7]  Y. Zhuang,et al.  Increased intratumoral IL-22-producing CD4+ T cells and Th22 cells correlate with gastric cancer progression and predict poor patient survival , 2012, Cancer Immunology, Immunotherapy.

[8]  Wei Li,et al.  Increased Frequencies of Th22 Cells as well as Th17 Cells in the Peripheral Blood of Patients with Ankylosing Spondylitis and Rheumatoid Arthritis , 2012, PloS one.

[9]  I. Frydecka,et al.  Dysregulated Expression of Both the Costimulatory CD28 and Inhibitory CTLA-4 Molecules in PB T Cells of Advanced Cervical Cancer Patients Suggests Systemic Immunosuppression Related to Disease Progression , 2011, Pathology & Oncology Research.

[10]  Zheng W. Chen,et al.  Virus infection stages and distinct Th1 or Th17/Th22 T-cell responses in malaria/SHIV coinfection correlate with different outcomes of disease. , 2011, The Journal of infectious diseases.

[11]  Xuping Wang,et al.  The imbalance of Th17/Treg in patients with uterine cervical cancer. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[12]  D. Artis,et al.  Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22 , 2011, Nature Immunology.

[13]  S. Rutz,et al.  Regulation and functions of the IL-10 family of cytokines in inflammation and disease. , 2011, Annual review of immunology.

[14]  R. Flavell,et al.  Recent advances in IL-22 biology. , 2011, International immunology.

[15]  A. Blauvelt,et al.  Circulating Th17, Th22, and Th1 cells are increased in psoriasis. , 2010, The Journal of investigative dermatology.

[16]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[17]  R. Sabat,et al.  Biology of interleukin-22 , 2010, Seminars in Immunopathology.

[18]  S. Durham,et al.  Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. , 2009, The Journal of clinical investigation.

[19]  D. Jarrossay,et al.  Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells , 2009, Nature Immunology.

[20]  H. Spits,et al.  Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from TH-17, TH1 and TH2 cells , 2009, Nature Immunology.

[21]  M. Neurath,et al.  STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing , 2009, The Journal of experimental medicine.

[22]  M. Brahic,et al.  Interleukin 22 Is a Candidate Gene for Tmevp3, a Locus Controlling Theiler's Virus-Induced Neurological Diseases , 2007, Genetics.

[23]  Wen‐Chun Chang,et al.  Immune concept of human papillomaviruses and related antigens in local cancer milieu of human cervical neoplasia , 2007, The journal of obstetrics and gynaecology research.

[24]  P. Valdez,et al.  Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis , 2007, Nature.

[25]  Qiang Tian,et al.  Expression and regulation of IL-22 in the IL-17-producing CD4+ T lymphocytes , 2006, Cell Research.

[26]  L. Fouser,et al.  Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides , 2006, The Journal of experimental medicine.

[27]  Z. Trajanoski,et al.  Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome , 2006, Science.

[28]  D. Littman,et al.  The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells , 2006, Cell.

[29]  L. Laimins,et al.  Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity , 2006, Reviews in medical virology.

[30]  Chien-Nan Lee,et al.  Induction of human papillomavirus type 16‐specific immunologic responses in a normal and an human papillomavirus‐infected populations , 2005, Immunology.

[31]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[32]  L. Chow,et al.  Immune responses to human papillomavirus in genital tract of women with cervical cancer. , 2005, Gynecologic oncology.

[33]  C J L M Meijer,et al.  The causal relation between human papillomavirus and cervical cancer. , 2002, Journal of clinical pathology.

[34]  V. Moreno,et al.  Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective , 1995 .

[35]  V. Gopalakrishna,et al.  Analysis by polymerase chain reaction of the physical state of human papillomavirus type 16 DNA in cervical preneoplastic and neoplastic lesions. , 1992, The Journal of general virology.

[36]  S. Wilczynski,et al.  Human papillomaviruses and cervical cancer: analysis of histopathologic features associated with different viral types. , 1988, Human pathology.

[37]  Jing Zhao,et al.  Chinese a Nti鄄 Cancer a Ssociation , 2022 .

[38]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[39]  D. Artis,et al.  Functional biology of the IL-22-IL-22R pathway in regulating immunity and inflammation at barrier surfaces. , 2010, Advances in immunology.

[40]  D. Littman,et al.  The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. , 2006, Cell.

[41]  G. Plautz,et al.  CD4+ T cells in adoptive immunotherapy and the indirect mechanism of tumor rejection. , 2000, Critical reviews in immunology.

[42]  V. Moreno,et al.  Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. , 1995, Journal of the National Cancer Institute.

[43]  T. Eberlein,et al.  The role of CD4+ tumor-infiltrating lymphocytes in human solid tumors , 1995, Immunologic research.